FR08C0007I2 - TRIAZOLYLTROPANE DERIVATIVES USED AS CCR5 MODULATORS - Google Patents

TRIAZOLYLTROPANE DERIVATIVES USED AS CCR5 MODULATORS

Info

Publication number: FR08C0007I2
Authority: FR; France
Prior art keywords: triazolyltropane; derivatives used; ccr5 modulators; ccr5; modulators
Prior art date: 2000-05-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR08C0007C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-05-26

Filing date

2008-03-04

Publication date

2009-01-15

2000-05-26 Priority claimed from GB0014046A external-priority patent/GB0014046D0/en

2000-06-27 Priority claimed from GB0015835A external-priority patent/GB0015835D0/en

2008-03-04 Application filed by Pfizer Inc filed Critical Pfizer Inc

2008-04-25 Publication of FR08C0007I1 publication Critical patent/FR08C0007I1/fr

2009-01-15 Application granted granted Critical

2009-01-15 Publication of FR08C0007I2 publication Critical patent/FR08C0007I2/en

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Obesity (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Molecular Biology (AREA)
Orthopedic Medicine & Surgery (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Emergency Medicine (AREA)
Transplantation (AREA)

FR08C0007C 2000-05-26 2008-03-04 TRIAZOLYLTROPANE DERIVATIVES USED AS CCR5 MODULATORS Active FR08C0007I2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB0014046A GB0014046D0 (en)	2000-05-26	2000-05-26	Compounds useful in therapy
GB0015835A GB0015835D0 (en)	2000-06-27	2000-06-27	Compounds useful in therapy
PCT/IB2001/000806 WO2001090106A2 (en)	2000-05-26	2001-05-09	Tryasolyl tropane derivatives as ccr5 modulators

Publications (2)

Publication Number	Publication Date
FR08C0007I1 FR08C0007I1 (en)	2008-04-25
FR08C0007I2 true FR08C0007I2 (en)	2009-01-15

Family

ID=26244452

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR08C0007C Active FR08C0007I2 (en)	2000-05-26	2008-03-04	TRIAZOLYLTROPANE DERIVATIVES USED AS CCR5 MODULATORS

Country Status (51)

Country	Link
EP (3)	EP1284974B1 (en)
JP (2)	JP3693957B2 (en)
KR (2)	KR100523501B1 (en)
CN (2)	CN100355753C (en)
AP (1)	AP1965A (en)
AR (2)	AR028622A1 (en)
AT (2)	ATE260914T1 (en)
AU (2)	AU2001252482B2 (en)
BG (1)	BG65966B1 (en)
BR (1)	BRPI0110955B8 (en)
CA (1)	CA2408909C (en)
CR (1)	CR10145A (en)
CU (1)	CU23288B7 (en)
CY (3)	CY2008006I1 (en)
CZ (1)	CZ299102B6 (en)
DE (3)	DE60102233T2 (en)
DK (2)	DK1526134T3 (en)
DZ (1)	DZ3464A1 (en)
EA (2)	EA007580B1 (en)
EE (1)	EE05110B1 (en)
EG (1)	EG24137A (en)
ES (3)	ES2311126T3 (en)
FR (1)	FR08C0007I2 (en)
GE (1)	GEP20063799B (en)
HK (3)	HK1054927A1 (en)
HR (1)	HRP20020938B1 (en)
HU (1)	HU225810B1 (en)
IL (2)	IL152531A0 (en)
IS (1)	IS2511B (en)
LT (1)	LTC1284974I2 (en)
LU (1)	LU91417I2 (en)
MA (1)	MA26902A1 (en)
ME (1)	ME00555A (en)
MX (1)	MXPA02011631A (en)
MY (3)	MY156920A (en)
NL (1)	NL300338I2 (en)
NO (3)	NO327892B1 (en)
NZ (1)	NZ521477A (en)
OA (1)	OA12264A (en)
PA (1)	PA8517101A1 (en)
PE (1)	PE20011371A1 (en)
PL (1)	PL200551B1 (en)
PT (2)	PT1284974E (en)
RS (2)	RS50904B (en)
SI (2)	SI1526134T1 (en)
SK (1)	SK286129B6 (en)
TN (1)	TNSN01077A1 (en)
TR (1)	TR200400541T4 (en)
TW (1)	TWI230160B (en)
UY (1)	UY26727A1 (en)
WO (1)	WO2001090106A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GEP20063799B (en) *	2000-05-26	2006-04-25	Pfizer	Tropane derivatives useful in therapy
RU2003137766A (en) *	2001-06-12	2005-05-20	Ск Корпорейшн (Kr)	NEW Phenylalkyl analogues of diamines and amides
SE0200919D0 (en) *	2002-03-25	2002-03-25	Astrazeneca Ab	Chemical compounds
GB0208071D0 (en) *	2002-04-08	2002-05-22	Pfizer Ltd	Tropane derivatives useful in therapy
WO2003084954A1 (en) *	2002-04-08	2003-10-16	Pfizer Limited	Tropane derivatives as ccr5 modulators
US6855724B2 (en)	2002-04-08	2005-02-15	Agouron Pharmaceuticals, Inc.	Tropane derivatives useful in therapy
BR0309982A (en) *	2002-05-23	2005-03-22	Pfizer	Method for identifying a ligand, by which the residence time at the receptor is measured
WO2004054581A2 (en) *	2002-12-13	2004-07-01	Smithkline Beecham Corporation	Cyclohexyl compounds as ccr5 antagonists
DE10336274A1 (en) *	2003-08-07	2005-03-10	Honeywell Specialty Chemicals	Process for the preparation of geminal difluoroalkanes
NZ545748A (en)	2003-08-29	2010-03-26	Ranbaxy Lab Ltd	Isoxazoline derivatives as inhibitors of phosphodiesterase type-IV
EP1786816A4 (en)	2003-09-10	2009-11-04	Virochem Pharma Inc	Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
PL1682545T3 (en)	2003-10-03	2008-04-30	Pfizer	Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
TW200610761A (en) *	2004-04-23	2006-04-01	Astrazeneca Ab	Chemical compounds
RU2006146608A (en)	2004-06-09	2008-07-20	Ф.Хоффманн-Ля Рош Аг (Ch)	OCTAGHYDROPYRROLO [3,4-c]-DERIVATIVES AND THEIR APPLICATION AS ANTIVIRAL AGENTS
CA2586231A1 (en) *	2004-11-19	2006-05-26	Boehringer Ingelheim International Gmbh	Method for treating hiv infection through co-administration of tipranavir and uk-427, 857
WO2006064340A2 (en) *	2004-12-13	2006-06-22	Pfizer Limited	Process for the preparation of n-acyl beta-aminoaldehydes
US7665658B2 (en)	2005-06-07	2010-02-23	First Data Corporation	Dynamic aggregation of payment transactions
MX2008000984A (en)	2005-07-22	2008-04-04	Progenics Pharm Inc	Methods for reducing viral load in hiv-1-infected patients.
CN101291905A (en)	2005-10-19	2008-10-22	弗·哈夫曼-拉罗切有限公司	Phenyl-acetamide nnrt inhibitors
AU2007286345B2 (en)	2006-08-16	2012-03-08	F. Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
US7932235B2 (en)	2006-11-17	2011-04-26	Concert Pharmaceuticals, Inc.	Triazolyl tropane derivatives
ES2550152T3 (en)	2006-12-13	2015-11-04	F. Hoffmann-La Roche Ag	2- (Piperidin-4-yl) -4-phenoxy-or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors
AU2007333667A1 (en) *	2006-12-19	2008-06-26	Auspex Pharmaceuticals, Inc.	Preperation and utility of CCR5 inhibitors
US20080207659A1 (en)	2007-02-15	2008-08-28	Asit Kumar Chakraborti	Inhibitors of phosphodiesterase type 4
WO2008132128A2 (en) *	2007-04-27	2008-11-06	Solvay (Société Anonyme)	Synthesis of a pharmaceutically active compound
US20110059154A1 (en) *	2008-02-29	2011-03-10	Strizki Julie M	Ccr5 antagonists as prophylactics for preventing hiv infection and methods of inhibiting transmission of same
CN101712679B (en) *	2008-10-08	2013-04-10	中国科学院上海药物研究所	Acylamide class compound, medicine composition, preparation method and application thereof
US8592395B2 (en) *	2009-07-24	2013-11-26	Glaxosmithkline Llc	Therapeutic compounds
CN102140104B (en) *	2010-02-03	2014-11-12	中国科学院上海药物研究所	1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition
BR112012024522A2 (en)	2010-04-02	2017-08-08	Phivco 1 Llc	combination, use of a combination, pharmaceutical composition, single dosage form, kit, and method for treating a disorder
CN106977511B (en) *	2011-12-19	2019-04-12	中国科学院上海药物研究所	A kind of aminopropyl replaces tropane aminated compounds, its pharmaceutical composition and its preparation method and application
EP2912047B1 (en)	2012-10-29	2016-08-24	Cipla Limited	Antiviral phosphonate analogues and process for preparation thereof
CZ306455B6 (en)	2013-04-26	2017-02-01	Zentiva, K.S.	A new method of Maraviroc synthesis
CN103497164B (en) *	2013-09-23	2015-12-23	西安近代化学研究所	A kind of anthracene derivant and preparation method thereof
CN104304248B (en) *	2014-10-23	2016-08-10	西北农林科技大学	3-arylpropionic acid ester type compound is as the application preparing miticide
CN104402883B (en) *	2014-10-24	2016-04-27	艾琪康医药科技（上海）有限公司	4,4-difluoro diamantane carboxamides derivatives, pharmaceutical composition and its production and use
CN104387379B (en) *	2014-11-26	2017-01-11	扬州氟药科技有限公司	Difluoro methylene piperidine carboxamide derivative as well as preparation method and application thereof
CN104860946A (en) *	2015-05-14	2015-08-26	湖北生物医药产业技术研究院有限公司	Preparation method of CCR5 antagonist
CN107879963A (en) *	2016-09-29	2018-04-06	中国科学院上海药物研究所	Novel chiral ligands, metallo-chelate, a variety of alpha-non-natural amino acids, the synthetic method of Malawi's promise and its key intermediate
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (en)	1990-01-23	1999-01-15	.	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5648511A (en) *	1990-11-19	1997-07-15	G.D. Searle & Co.	Method for making intermediates useful in the synthesis of retroviral protease inhibitors
FR2676444B1 (en) *	1991-05-16	1995-03-10	Sanofi Elf	NOVEL AMINO-3 PYRIDAZINE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
GB9310713D0 (en) *	1993-05-24	1993-07-07	Zeneca Ltd	Aryl substituted heterocycles
SK280875B6 (en) *	1994-04-19	2000-08-14	Neurosearch A/S	Tropane derivatives, method of their preparation, pharmaceutical compositions, use of these tropane derivatives for the preparation of medicaments
GB9523526D0 (en) *	1995-11-17	1996-01-17	Zeneca Ltd	Therapeutic compounds
DE19546462A1 (en) *	1995-12-13	1997-06-19	Bayer Ag	Diarylacetylene ketones
AU1208397A (en) *	1995-12-28	1997-07-28	Takeda Chemical Industries Ltd.	Diphenylmethane derivatives as mip-1alpha/rantes receptor antagonists
US6323206B1 (en) *	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
AU729415B2 (en) *	1996-07-12	2001-02-01	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
AU5604998A (en) *	1996-12-13	1998-07-03	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
WO1998025617A1 (en)	1996-12-13	1998-06-18	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
WO1999004794A1 (en) *	1997-07-25	1999-02-04	Merck & Co., Inc.	Cyclic amine modulators of chemokine receptor activity
IL125658A0 (en) *	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists
AR013669A1 (en) *	1997-10-07	2001-01-10	Smithkline Beecham Corp	COMPOUNDS AND METHODS
AU2335699A (en) *	1998-01-21	1999-08-09	Kyowa Hakko Kogyo Co. Ltd.	Chemokine receptor antagonists and methods of use therefor
PE20001420A1 (en) *	1998-12-23	2000-12-18	Pfizer	CCR5 MODULATORS
US7217714B1 (en) *	1998-12-23	2007-05-15	Agouron Pharmaceuticals, Inc.	CCR5 modulators
EP1013276A1 (en)	1998-12-23	2000-06-28	Pfizer Inc.	Aminoazacycloalkanes as CCR5 modulators
GEP20063799B (en) *	2000-05-26	2006-04-25	Pfizer	Tropane derivatives useful in therapy

2001
- 2001-05-09 GE GEAP2001004960 patent/GEP20063799B/en unknown
- 2001-05-09 SI SI200130862T patent/SI1526134T1/en unknown
- 2001-05-09 DK DK04004193T patent/DK1526134T3/en active
- 2001-05-09 JP JP2001586293A patent/JP3693957B2/en not_active Expired - Lifetime
- 2001-05-09 CN CNB2005100068151A patent/CN100355753C/en not_active Expired - Lifetime
- 2001-05-09 EE EEP200200656A patent/EE05110B1/en active Protection Beyond IP Right Term
- 2001-05-09 ES ES04004193T patent/ES2311126T3/en not_active Expired - Lifetime
- 2001-05-09 PT PT01925808T patent/PT1284974E/en unknown
- 2001-05-09 AT AT01925808T patent/ATE260914T1/en active
- 2001-05-09 RS YUP82202 patent/RS50904B/en unknown
- 2001-05-09 AU AU2001252482A patent/AU2001252482B2/en not_active Expired
- 2001-05-09 AT AT04004193T patent/ATE407134T1/en active
- 2001-05-09 IL IL15253101A patent/IL152531A0/en unknown
- 2001-05-09 EA EA200401056A patent/EA007580B1/en not_active IP Right Cessation
- 2001-05-09 ES ES01925808T patent/ES2215129T3/en not_active Expired - Lifetime
- 2001-05-09 HU HU0302474A patent/HU225810B1/en active Protection Beyond IP Right Term
- 2001-05-09 RS RSP-2009/0438A patent/RS51436B/en unknown
- 2001-05-09 PL PL359267A patent/PL200551B1/en unknown
- 2001-05-09 TR TR200400541T patent/TR200400541T4/en unknown
- 2001-05-09 AU AU5248201A patent/AU5248201A/en active Pending
- 2001-05-09 PT PT04004193T patent/PT1526134E/en unknown
- 2001-05-09 DE DE2001602233 patent/DE60102233T2/en not_active Expired - Lifetime
- 2001-05-09 ES ES08163025T patent/ES2401812T3/en not_active Expired - Lifetime
- 2001-05-09 WO PCT/IB2001/000806 patent/WO2001090106A2/en active IP Right Grant
- 2001-05-09 KR KR10-2002-7015934A patent/KR100523501B1/en active IP Right Grant
- 2001-05-09 CA CA 2408909 patent/CA2408909C/en not_active Expired - Lifetime
- 2001-05-09 OA OA1200200343A patent/OA12264A/en unknown
- 2001-05-09 EP EP20010925808 patent/EP1284974B1/en not_active Expired - Lifetime
- 2001-05-09 CN CNB018088287A patent/CN1279040C/en not_active Expired - Lifetime
- 2001-05-09 DZ DZ013464A patent/DZ3464A1/fr active
- 2001-05-09 BR BRPI0110955A patent/BRPI0110955B8/en not_active IP Right Cessation
- 2001-05-09 EP EP20080163025 patent/EP1990341B1/en not_active Expired - Lifetime
- 2001-05-09 ME MEP-693/08A patent/ME00555A/en unknown
- 2001-05-09 KR KR1020057003492A patent/KR100548854B1/en active IP Right Grant
- 2001-05-09 AP APAP/P/2002/002663A patent/AP1965A/en active
- 2001-05-09 MX MXPA02011631A patent/MXPA02011631A/en active IP Right Grant
- 2001-05-09 SK SK1643-2002A patent/SK286129B6/en active Protection Beyond IP Right Term
- 2001-05-09 EP EP20040004193 patent/EP1526134B1/en not_active Expired - Lifetime
- 2001-05-09 SI SI200130090T patent/SI1284974T1/en unknown
- 2001-05-09 NZ NZ521477A patent/NZ521477A/en not_active IP Right Cessation
- 2001-05-09 EA EA200201141A patent/EA005382B1/en not_active IP Right Cessation
- 2001-05-09 DE DE200812000011 patent/DE122008000011I1/en active Pending
- 2001-05-09 CZ CZ20023806A patent/CZ299102B6/en not_active IP Right Cessation
- 2001-05-09 DK DK01925808T patent/DK1284974T3/en active
- 2001-05-09 DE DE60135685T patent/DE60135685D1/en not_active Expired - Lifetime
- 2001-05-21 TW TW90112055A patent/TWI230160B/en active
- 2001-05-22 PA PA8517101A patent/PA8517101A1/en unknown
- 2001-05-22 EG EG20010535A patent/EG24137A/en active
- 2001-05-23 MY MYPI20094132A patent/MY156920A/en unknown
- 2001-05-23 MY MYPI20041980 patent/MY153023A/en unknown
- 2001-05-23 MY MYPI20012461 patent/MY131019A/en unknown
- 2001-05-24 PE PE2001000476A patent/PE20011371A1/en active IP Right Grant
- 2001-05-24 AR ARP010102486 patent/AR028622A1/en active IP Right Grant
- 2001-05-24 UY UY26727A patent/UY26727A1/en not_active IP Right Cessation
- 2001-05-25 TN TNSN01077 patent/TNSN01077A1/en unknown
2002
- 2002-09-23 BG BG107140A patent/BG65966B1/en unknown
- 2002-09-24 IS IS6565A patent/IS2511B/en unknown
- 2002-10-28 IL IL152531A patent/IL152531A/en active Protection Beyond IP Right Term
- 2002-10-28 CU CU20020243A patent/CU23288B7/en unknown
- 2002-10-31 NO NO20025227A patent/NO327892B1/en not_active IP Right Cessation
- 2002-11-14 MA MA26910A patent/MA26902A1/en unknown
- 2002-11-26 HR HR20020938A patent/HRP20020938B1/en not_active IP Right Cessation
2003
- 2003-09-30 HK HK03107045A patent/HK1054927A1/en not_active IP Right Cessation
2005
- 2005-02-15 JP JP2005038062A patent/JP4854970B2/en not_active Expired - Lifetime
- 2005-11-18 HK HK05110416A patent/HK1078573A1/en not_active IP Right Cessation
2006
- 2006-10-18 HK HK06111446A patent/HK1090836A1/en not_active IP Right Cessation
2007
- 2007-03-27 AR ARP070101273 patent/AR060159A2/en unknown
2008
- 2008-02-22 NL NL300338C patent/NL300338I2/en unknown
- 2008-02-22 LU LU91417C patent/LU91417I2/en unknown
- 2008-02-25 LT LTPA2008004C patent/LTC1284974I2/en unknown
- 2008-03-04 FR FR08C0007C patent/FR08C0007I2/en active Active
- 2008-03-17 CY CY200800006C patent/CY2008006I1/en unknown
- 2008-07-16 CR CR10145A patent/CR10145A/en unknown
- 2008-10-24 CY CY081101203T patent/CY1108451T1/en unknown
2010
- 2010-04-08 NO NO2010007C patent/NO2010007I2/en unknown
2020
- 2020-06-30 NO NO2020019C patent/NO2020019I1/en not_active IP Right Cessation
2022
- 2022-04-19 CY CY2022009C patent/CY2022009I1/en unknown

Also Published As

Publication number	Publication date
IL152531A (en)	2010-05-17
AU5248201A (en)	2001-12-03
ME00555B (en)	2011-12-20
NO2010007I2 (en)	2013-09-09
MXPA02011631A (en)	2003-03-27
ME00555A (en)	2011-12-20
NO327892B1 (en)	2009-10-12
DK1284974T3 (en)	2004-06-07
ES2311126T3 (en)	2009-02-01
AU2001252482B2 (en)	2006-01-19
YU82202A (en)	2005-11-28
BRPI0110955B1 (en)	2016-06-28
LTPA2008004I1 (en)	2020-07-27
CY2008006I2 (en)	2009-11-04
MA26902A1 (en)	2004-12-20
AP2002002663A0 (en)	2002-12-31
LTC1284974I2 (en)	2020-11-10
CY2008006I1 (en)	2009-11-04
HUP0302474A2 (en)	2003-11-28
TR200400541T4 (en)	2004-04-21
CU23288B7 (en)	2008-06-30
AR060159A2 (en)	2008-05-28
PT1526134E (en)	2008-10-28
CY1108451T1 (en)	2014-04-09
ES2401812T3 (en)	2013-04-24
PE20011371A1 (en)	2002-01-18
HU225810B1 (en)	2007-10-29
SK16432002A3 (en)	2004-01-08
LU91417I9 (en)	2019-01-02
CZ20023806A3 (en)	2004-01-14
ATE260914T1 (en)	2004-03-15
EP1526134B1 (en)	2008-09-03
LU91417I2 (en)	2008-04-22
MY131019A (en)	2007-07-31
EP1284974B1 (en)	2004-03-03
FR08C0007I1 (en)	2008-04-25
DE60135685D1 (en)	2008-10-16
CA2408909A1 (en)	2001-11-29
CY2022009I2 (en)	2022-05-27
HK1078573A1 (en)	2006-03-17
KR100523501B1 (en)	2005-10-25
NO20025227L (en)	2002-10-31
ATE407134T1 (en)	2008-09-15
EP1526134A2 (en)	2005-04-27
CN1437599A (en)	2003-08-20
CN100355753C (en)	2007-12-19
TNSN01077A1 (en)	2005-11-10
NL300338I2 (en)	2008-06-02
CR10145A (en)	2008-08-19
JP3693957B2 (en)	2005-09-14
ES2215129T3 (en)	2004-10-01
SK286129B6 (en)	2008-04-07
AU2001252482C1 (en)	2001-12-03
CY2022009I1 (en)	2022-05-27
EP1990341A1 (en)	2008-11-12
DE122008000011I1 (en)	2008-06-05
RS50904B (en)	2010-08-31
NO2010007I1 (en)	2010-04-08
GEP20063799B (en)	2006-04-25
EE200200656A (en)	2004-06-15
IL152531A0 (en)	2003-05-29
JP4854970B2 (en)	2012-01-18
UY26727A1 (en)	2001-12-28
PT1284974E (en)	2004-06-30
OA12264A (en)	2003-11-10
BG107140A (en)	2003-05-30
HRP20020938B1 (en)	2011-05-31
NL300338I1 (en)	2008-05-01
HK1090836A1 (en)	2007-01-05
MY156920A (en)	2016-04-15
CZ299102B6 (en)	2008-04-23
PL359267A1 (en)	2004-08-23
MY153023A (en)	2014-12-31
EP1990341B1 (en)	2013-01-23
CN1680371A (en)	2005-10-12
EA200201141A1 (en)	2003-04-24
WO2001090106A3 (en)	2002-03-28
IS6565A (en)	2002-09-24
SI1526134T1 (en)	2008-12-31
KR20030004417A (en)	2003-01-14
KR20050046743A (en)	2005-05-18
PL200551B1 (en)	2009-01-30
EA005382B1 (en)	2005-02-24
EP1284974A2 (en)	2003-02-26
BR0110955A (en)	2003-06-03
HUP0302474A3 (en)	2007-05-29
CN1279040C (en)	2006-10-11
AP1965A (en)	2009-03-04
KR100548854B1 (en)	2006-02-02
PA8517101A1 (en)	2002-10-24
BRPI0110955B8 (en)	2021-05-25
DK1526134T3 (en)	2008-11-17
JP2003534343A (en)	2003-11-18
AR028622A1 (en)	2003-05-14
EP1526134A3 (en)	2006-11-29
NO2020019I1 (en)	2020-06-30
BG65966B1 (en)	2010-07-30
SI1284974T1 (en)	2004-08-31
HK1054927A1 (en)	2003-12-19
WO2001090106A2 (en)	2001-11-29
RS20090438A (en)	2010-05-07
RS51436B (en)	2011-04-30
NZ521477A (en)	2004-07-30
HRP20020938A2 (en)	2005-02-28
IS2511B (en)	2009-05-15
EA200401056A1 (en)	2005-04-28
DE60102233T2 (en)	2005-01-27
TWI230160B (en)	2005-04-01
CA2408909C (en)	2006-06-27
EG24137A (en)	2008-08-06
EE05110B1 (en)	2008-12-15
DE60102233D1 (en)	2004-04-08
JP2005194283A (en)	2005-07-21
DZ3464A1 (en)	2001-11-29
NO20025227D0 (en)	2002-10-31
EA007580B1 (en)	2006-12-29

Publication	Publication Date	Title
FR08C0007I2 (en)	2009-01-15	TRIAZOLYLTROPANE DERIVATIVES USED AS CCR5 MODULATORS
DZ3506A1 (en)	2002-11-28	PYRROLE DERIVATIVES FOR USE AS PHARMACEUTICAL AGENTS
DZ3439A1 (en)	2001-12-13	2-AMINOCARBONYL-9H-PURINE DERIVATIVES
FR15C0086I2 (en)	2016-06-03	HYDROXAMATE DERIVATIVES AS DESACETYLASE INHIBITORS
MA26344A1 (en)	2004-10-01	1,8-NAPHTYRIDINE DERIVATIVES FOR USE AS ANTIDIABETICS
AR028567A1 (en)	2003-05-14	NEW DERIVATIVES OF FENIL-PROPARGILETER
NO20031001D0 (en)	2003-03-04	Polyarylcarboxamides useful as lipid-lowering agents
CY2007029I1 (en)	2009-11-04	METHOD FOR THE PREPARATION OF SUBSTITUTED OCTANOYL-AMIDES
AR028596A1 (en)	2003-05-14	NEW DERIVATIVES OF PHENYLGLYCIN
PT1406628E (en)	2006-06-30	TERA-HYDROQUINOLINE DERIVATIVES
PT1303521E (en)	2005-05-31	TETRA-HYDRO-HETEROCYCLOAZEPINYL-PYRIMIDINE DERIVATIVES
AR028576A1 (en)	2003-05-14	USEFUL B-CARBOLINE DERIVATIVES AS PHOSPHODESTERASE INHIBITORS
PT1287001E (en)	2004-12-31	UTIOUS THYROFEN DERIVATIVES AS ANTICANCERIGENE AGENTS
DK1412328T3 (en)	2007-02-12	Dolastatin-10 derivatives
AR028575A1 (en)	2003-05-14	USED PIRROLOPIRIDINONE DERIVATIVES AS PHOSPHODESTERASE INHIBITORS
PT1250321E (en)	2006-09-29	COMPOSITION OF GLIBURIDA
NO20032632L (en)	2003-08-11	Waveform quality measurement
NO20032272D0 (en)	2003-05-20	Biphenylcarboxamides useful as lipid-lowering agents
DE60139754D1 (en)	2009-10-15	Quality Return procedures
FR2810318B1 (en)	2005-09-23	DIAMANO-PHENOTHIAZINE DERIVATIVES
EE200300294A (en)	2003-10-15	Process for the preparation of sulfonamide substituted imidazotriazinones
AR028602A1 (en)	2003-05-14	PIRROL DERIVATIVES
AR028282A1 (en)	2003-04-30	AMINOFENIL PIRIMIDONA DERIVATIVES
DK1317426T3 (en)	2006-01-09	Pay-thio-amino acids
PT1322592E (en)	2004-12-31	SUBSTITUTED DERIVATIVES OF 1-AMINOBUTAN-3-OL